Uncovering the PML::RARA Fusion in Cytogenetically Cryptic and FISH-Negative Acute Promyelocytic Leukemia—A Case Report and Comprehensive Literature Review
Genes · 2025
DOI: 10.3390/genes16101159 ↗Kurz gefasst
Fallbericht in der Zeitschrift Genes, 2025. Verfasst von Busra N Delikkaya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hematopathology, Department of Pathology and Genomic Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA. Hauptthemen laut MEDLINE: Leukemia, Promyelocytic, Acute, Oncogene Proteins, Fusion, Retinoic Acid Receptor alpha, Promyelocytic Leukemia Protein. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The PML::RARA fusion resulting from t(15;17) is the genetic hallmark of acute promyelocytic leukemia (APL), typically detected by cytogenetics and/or fluorescence in situ hybridization (FISH) studies. Rarely, APL patients present with normal cytogenetics and FISH findings, complicating diagnosis and delaying life-saving therapy. We report a 23-year-old male with clinical, morphologic and immunophenotypic features consistent with APL but negative for FISH studies. Despite prompt initiation of all-trans retinoic acid (ATRA) based on clinical suspicion, the patient succumbed to intracranial hemorrhage. Quantitative reverse transcriptase PCR (qRT-PCR) confirmed a long isoform PML::RARA fusion. A review of 34 published cytogenetics- and FISH-negative cases since 1995 demonstrates that RT-PCR-based methods reliably detect cryptic fusions. While advanced genomic approaches may identify these fusions at higher resolution, their accessibility, complexity, cost, and turnaround time often limit diagnostic utility in the urgent setting of APL. Given the extreme rarity of this subset, cytogenetics and FISH remain the standard frontline tests; however, these cases underscore the critical need to incorporate molecular testing into routine workflows. Early recognition and timely therapy are essential to reducing mortality in cryptic APL, and these cases also provide insight into mechanisms of atypical leukemia biology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hematopathology, Department of Pathology and Genomic Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA.
- Clinical Cytogenomics Laboratory, Department of Pathology and Genomic Medicine, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
ORCID-Profile: Busra N Delikkaya
Zitieren
APA
Delikkaya, B. N., Eberle-Singh, J., Morton, A. B., Gong, J. Z., & Liu, J. (2025). Uncovering the PML::RARA Fusion in Cytogenetically Cryptic and FISH-Negative Acute Promyelocytic Leukemia—A Case Report and Comprehensive Literature Review. Genes. https://doi.org/10.3390/genes16101159
Vancouver
Delikkaya BN, Eberle-Singh J, Morton AB, Gong JZ, Liu J. Uncovering the PML::RARA Fusion in Cytogenetically Cryptic and FISH-Negative Acute Promyelocytic Leukemia—A Case Report and Comprehensive Literature Review. Genes. 2025. doi:10.3390/genes16101159
BibTeX
@article{Delikkaya2025,
author = {Delikkaya, Busra N and Eberle-Singh, Jaime and Morton, Arianna B and Gong, Jerald Z and Liu, Jinglan},
title = {Uncovering the PML::RARA Fusion in Cytogenetically Cryptic and FISH-Negative Acute Promyelocytic Leukemia—A Case Report and Comprehensive Literature Review},
journal = {Genes},
year = {2025},
doi = {10.3390/genes16101159}
}
EUVIMED